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Thyroid-stimulating hormone within  
low-normal range is related to  
imbalance of bone remodeling  
in euthyroid postmenopausal women 
with osteoporotic fractures
AbsTrAcT
Introduction. Data relating to thyroid-stimulating hormone (TSH) and risk of fractures are limited, and the 
effect of TSH within the normal range on bone mineral density (BMD) and bone remodelling is contro-
versial. We aimed to evaluate whether variations across TSH concentration within the normal range are 
associated with bone metabolism expressed by bone remodeling markers in euthyroid postmenopausal 
women with osteoporotic fractures.
Material and methods. The study group consisted of 60 elderly women admitted to the hospital due to 
nonvertebral osteoporotic fractures of which 57 were diagnosed as euthyroid. In all serum fT4, and TSH, 
P1NP (a bone formation marker) and CTX (a bone resorption marker) were measured.
Results. The majority of fractures occurred at the lower TSH tertile (0.14–2.19 mIU/L). Most of the patients 
(70%) in this tertile had TSH value below 1 mIU/L. There was a clear tendency towards lower P1NP in the 
first TSH tertile (p = 0.056 and p = 0.057) whereas most CTX values tended to be higher than the median 
concentration in the whole group. A significant positive correlation between TSH and P1NP was observed 
(r = 0.32; p = 0.01). TSH within the normal range and CTX explained 25% of the variability of P1NP in 
euthyroid women with osteoporotic fractures.
Conclusions. In elderly euthyroid women low-normal TSH level seems to be associated with the imbalance 
between bone resorption and formation. Diminished bone formation may predispose to increased risk of 
nonvertebral fractures. Bone marker testing in subjects with low-normal TSH may add new value in the 
assessment of fracture risk. 
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Introduction
Thyroid hormones are involved in the regulation 
of bone metabolism, being essential for normal bone 
development. Hyperthyroidism in adults is related 
to increased bone turnover and bone loss and was 
shown to be associated with an increased lifetime risk 
for fractures [1]. In hypothyroidism bone metabolism is 
supressed and bone mineral density (BMD) increased, 
but the fracture risk remains elevated. Data relating to 
thyroid-stimulating hormone (TSH) and risk of frac-
tures are limited, and the effect of TSH concentrations 
remaining within the normal range on BMD and bone 
turnover markers is a matter of controversy. TSH has 
been shown to be related with bone remodeling markers 
independently of thyroid hormone concentrations [2]. 
The results of in vitro experiments support the observa-
tions that TSH negatively regulates osteoclastogenesis 
and exerts a protective effect on bone [3]. According 
to recent reports, variations of serum TSH within the 
physiological range do not greatly influence BMD and 
there is no correlation between bone turnover markers 
and TSH [4, 5]. On the other hand, subclinical hyper-
thyroidism, and even thyroid function within the upper 
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normal range, have been shown to affect bone density 
and the risk of nonvertebral fractures in postmenopausal 
women [6, 7]. Maziotti et al. found that low-normal TSH 
is related to high prevalence of vertebral fractures in 
post-menopausal women with osteoporosis or osteo-
paenia, independently of thyroid hormones, age, and 
BMD [8]. Therefore, we aimed to evaluate whether 
variation across TSH concentration, within the reference 
range, is associated with bone metabolism expressed 
by changes in biochemical bone remodeling markers 




Our study group consisted of 60 women with mean 
age 77 (61–85) years admitted to the Department of 
Orthopaedics and Traumatology at the University Hos-
pital in Bydgoszcz due to osteoporotic fracture. 76% of 
patients had femoral neck fracture and 24% had fractures 
of hip or knee joint. All women were postmenopausal and 
previously had not received any drugs affecting bone 
metabolism. Other inclusion criteria were as follows: no 
clinical history of recent significant trauma or prolonged 
immobilisation, absence of thyroid diseases, and no thy-
roid hormone replacement therapy. Thyroid function was 
defined by measurement of serum free-thyroxine (fT4), 
and serum TSH was assayed. Moreover, all patients were 
asked to fill-in the questionnaire on chronic diseases, 
personal history of fractures, taken drugs, and vitamin 
supplements. A  total of 57 patients were euthyroid 
(fT4 0.7–1.48 ng/dL; TSH > 0.1– < 10 mIU/L) [7, 9], and 
three had subclinical hyperthyroidism (TSH < 0.1 mIU/L). 
We observed no relationship between TSH and fT4 in 
our study group, which supports the premise that we 
studied euthyroid patients (p = 0.29) [5]. 
Written, informed consent was obtained from all 
subjects. The study was approved by the Bioethics 
Committee at Collegium Medicum, Nicolaus Coperni-
cus University.
Blood sampling and laboratory analyses
Non-fasting venous blood samples were collected 
from patients within 18 hours after fracture. Blood sam-
ples were collected at the same time of day (between 
8:00 and 15:00 a.m.) to mitigate the effects of diurnal 
variation. There was no influence of the blood collection 
time on any parameters under study (Kruskal-Wallis test 
p > 0.09). Serum was obtained within two hours to avoid 
proteolysis and stored deep-frozen at –70°C in small 
aliquots until assayed. TSH and fT4 were measured on 
an automated analyser using the ci8200 ARCHITECT 
System (Abbott Diagnostics; TSH detection limit of 
0.01 mIU/L, which meets the requirements of a  third 
generation TSH assay; fT4 detection limit of 0.4 ng/dL).
In the serum samples, directly after thawing, the fol-
lowing bone markers were measured: total propeptide 
of type 1 procollagen (P1NP), a bone formation marker 
(ECLIA Elecsys, ROCHE Diagnostics; detection limit 
5 ng/mL; mid-95th percentile range for postmenopausal 
women 42.94–76.31 ng/mL), C-terminal telopeptide of 
type 1 collagen (CTX), a bone resorption marker (CTx 
ELISA, Immunodiagnostic Systems; detection limit 
0,02 ng/mL; mean value for postmenopausal women 
0.439 ng/mL; range 0.142–1.351 ng/mL).
Statistical analysis
Statistical analysis was performed using Statistica 
10.0 for Windows (Stat Soft) and statistical package 
PQStat ver. 1.4.2.324. Data were assessed for normal 
distribution using the Shapiro-Wilk test. All data are 
presented as median (Q1–Q3) because of non-Gauss-
ian distribution. TSH levels were grouped into tertiles, 
and between tertiles Kruskal-Wallis one-way analysis 
of variance by ranks was performed. Spearman’s rank 
correlation test and partial correlation between TSH 
and bone turnover markers, with the effect of age, 
were used. Multivariable regression analysis to assess 
the independent contributions of different variables to 
serum P1NP concentration was performed. Statistical 
significance was assumed when the p-value was equal 
to or less than 0.05, and a highly significant probability 
test was taken at the level of p < 0.01. 
results
A  group of euthyroid women with osteoporotic 
fracture was characterised by median TSH, and fT4, 
of 0.82 (0.57–1.55) mIU/L and 1.22 (1.11–1.32) ng/dL, 
respectively. Median concentrations of bone turnover 
markers CTX and P1NP were 0.535 (0.369–0.832) 
ng/mL and 47.3 (34.7–66.9) ng/mL, respectively.
The association between TSH concentration across 
tertiles and frequency of fractures is shown in Figure 1. 
The majority of fractures (84%) occurred in the first ter-
tile, at the lowest TSH from 0.14 to 2.19 mIU/L, whereas 
only 5% of fractures occurred in women with TSH in the 
higher tertile (TSH 4.27–6.31 mIU/L). 
The general characteristics of the study participants 
according to TSH tertiles is given in Table 1. The TSH 
concentration in the first tertile was significantly lower 
compared to that in other tertiles (p = 0.004); in fact, 
70% of cases in this tertile had a  TSH value below 
1 mIU/L. The lowest concentrations of bone forma-
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Table 1. General characteristics, thyroid parameters, and bone turnover markers of euthyroid postmenopausal 
women with osteoporotic fractures, according to TSH tertiles; Median (Q1–Q3)
TSH 
1st tertile 
0.14 to 2.19 mIU/L
2nd tertile
2.20 to 4.26 mIU/L
3rd tertile

























Table 2. Correlations between TSH, age, and bone 
turnover markers
TSH CTX
Age (years) r = 0.12
p < 0.3
r = 0.25 
p < 0.05




Figure 1. Occurrence of fractures in euthyroid post-
menopausal women according to TSH tertiles; p < 0.001. 
Tertile 1 vs. tertile 2 and tertile 3
tion marker P1NP was found in the lower TSH tertile 
(p = 0.056 and p = 0.057, respectively). Low P1NP 
concentrations (below the median in the whole group) 
were found in 54% of patients with TSH 0.14–2.19 mIU/L, 
and this proportion was nearly two-fold higher com-
pared to 2nd tertile. None of the patients in the high tertile 
had a P1NP below the median value. Concomitant low 
bone formation markers in this subgroup and higher 
CTX values (over the median) were found in 60% of 
women. At TSH over 2.20 mIU/L this proportion was 
slightly higher (70%). 
In euthyroid women with fractures a weak but highly 
significant positive correlation between TSH and P1NP 
was observed (r = 0.32; p = 0.01), which remained 
significant when adjusted for age. We observed no 
relationship either between TSH and other analysed 
parameters or between thyroid hormones and analysed 
variables. 
When rank correlations were analysed in TSH tertiles 
the relationship of P1NP with TSH remained positive 
and significant (p = 0.25; p < 0.05) in the lower tertile, 
and a weak tendency to inverse association of TSH and 
CTX could be noticed. 
Moreover, CTX concentration was positively re-
lated with age (r = 0.25; p < 0.05) whereas CTX was 
significantly positively correlated with P1NP (r = 0.52; 
p < 0.00002) (Tab. 2).
Multivariable regression analysis was performed 
to assess the independent contributions of different 
variables to serum P1NP concentration in the whole 
study group. According to the results of bivariate cor-
relation analysis, only TSH and CTX were taken into 
account (Tab. 3). Both TSH and CTX explained 25% of 
the variability of serum P1NP in euthyroid women with 
osteoporotic fractures. 
Discussion
This study shows that TSH variation within the phys-
iological range is related to bone remodeling markers in 
postmenopausal euthyroid women who have sustained 
nonvertebral fragility fractures. The majority of fractures 
occurred at TSH concentrations in the lower tertile, and 
this was associated with the lowest concentrations 
of bone formation marker-P1NP. Interestingly, bone 
resorption in patients with low-normal TSH remained 
within the upper reference range. Our data support 
the concept of the imbalance between bone resorption 
and bone formation in elderly euthyroid women with 
low-normal TSH levels and may suggest increased risk 
of nonvertebral (mostly hip) fractures. 
The effect of TSH variations within the physiological 
range on BMD and bone turnover markers have been 
a  matter of controversy. Maziotti et al. in a  selected 
group of euthyroid postmenopausal women with low 
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Table 3. Multiple regression analysis on serum P1NP
Independent 
variable
Adjusted R2 F b p
P1NP 0.25 12.4 < 0.00002
TSH 0.19 < 0.07
CTX 0.43 < 0.0009
bone mineral density showed that low-normal TSH 
levels are associated with high prevalence of vertebral 
fractures independently of thyroid hormones, age, and 
BMD [8]. In their study bone turnover markers were not 
measured, but the authors suggest additional measur-
ing of TSH in postmenopausal women with osteopae-
nia and osteoporosis, even in the absence of thyroid 
disorders, because TSH levels below 1 mIU/L may pre-
dispose to vertebral fractures [8]. Another recent report 
by Murphy et al. showed that thyroid function within 
the upper-normal range is related to reduced BMD at 
the hip and increased risk of nonvertebral fractures in 
postmenopausal euthyroid women. However, in their 
study no relationship was found between TSH and BMD 
and bone turnover marker alterations [7]. Similarly, Roef 
et al., in a study performed in healthy men at the age of 
peak bone mass, observed that thyroid hormone status 
within the physiological range influences bone mass 
and density but has no relationship with bone formation 
marker P1NP and bone resorption marker CTX [5]. 
Our study was performed in women with sustained 
fragility fractures, and we found a positive significant 
correlation between serum TSH within the normal range 
and P1NP, a  bone formation marker. Moreover, we 
showed that the majority of women with fractures in the 
lower TSH tertile had the lowest P1NP values and below 
the median for the whole group (< 47.3 ng/mL). In fact, 
the median P1NP concentration in our study group with 
fractures was lower than that reported by others for age-
matched, postmenopausal women with osteoporosis 
[7, 10, 11]. On the other hand, median CTX in the lower 
TSH tertile, which remained within the reference range 
for age, and in the whole study group, was much higher 
than that observed by others [7, 10]. Zhao et al. found 
significantly higher levels of serum b-CTX in Chinese 
postmenopausal women with sustained osteoporotic 
fracture or vertebral fracture but no association of P1NP 
with vertebral fractures [10]. Our data suggest the pos-
sibility of uncoupling of the bone remodeling process 
in elderly women, particularly with low-normal TSH that 
may predispose to nonvertebral fractures. This seems 
to be in line with another important finding in the present 
study, supported by multivariable regression analysis, 
which revealed that P1NP variation may, to some extent, 
be explained by CTX and TSH concentrations in elderly 
euthyroid women with fragility fractures. 
TSH has been reported to modulate bone remod-
eling independently of thyroid hormones, and a direct 
inhibitory effect on osteoclastic bone resorption has 
been shown [12]. TSH receptors in osteoclasts and 
osteoblasts were described, and reduced TSHR expres-
sion was found to be related to the development of oste-
oporosis [3]. We did not find any significant association 
of TSH with CTX because we studied a limited number 
of euthyroid women with TSH within the normal range. 
However, we did not observe significantly elevated 
CTX values across the TSH tertiles, as it was for P1NP. 
Therefore, we can only speculate that this could be an 
effect of a significant increase in TSH concentration. 
Our study has some limitations. We included only 
women with fragility fractures, and because of technical 
reasons we did not measure bone mineral density by 
DEXA. However, we evaluated bone remodeling pro-
cess with the most representative and recommended 
biochemical markers. The concentrations of biochemi-
cal bone markers were not always measured in the fast-
ing state; however, as shown previously, concentrations 
of these markers in the serum, particularly P1NP, are 
virtually unaffected by food intake, and we excluded the 
influence of blood collection time.
Finally, we conclude that in elderly euthyroid women 
low-normal TSH level may be associated with the imbal-
ance between bone resorption and bone formation. Di-
minished bone formation may predispose to increased 
risk of nonvertebral (mostly hip) fractures. Bone markers 
testing in subjects with low-normal TSH may add new 
value in the assessment of fracture risk.
Further studies should be designed to confirm the 
effect of TSH concentration within low-normal range on 
bone remodeling in a larger population. 
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